Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Braveheart Bio, Inc.BRVE · Entity 4564 | Director | August 07, 2026 | August 14, 2026 |
| TENET HEALTHCARE CORPTHC · Entity 2563 | Director | May 27, 2026 | May 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Braveheart Bio, Inc.
Report date August 07, 2026 · Filed August 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy AH Bio Fund IV, L.P. | 10,232,420 |
Reported balance
Holding disclosure · report date 2026-08-07 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 10,232,420 F1: The reported securities are held by AH Bio Fund IV, L.P. ("AH Bio Fund IV"), for itself and as nominee for AH Bio Fund IV-B, L.P., AH 2022 Annual Fund, L.P., AH 2022 Annual Fund-B, L.P., AH 2022 Annual Fund-QC, L.P. and CLF Partners III, LP. AH Equity Partners Bio IV, L.L.C. ("AH EP Bio IV") is the general partner of AH Bio Fund IV and has sole voting and dispositive power with regard to the securities held by AH Bio Fund IV for itself and as nominee. The managing members of AH EP Bio IV are Marc Andreessen and Ben Horowitz. Marc Andreessen and Ben Horowitz may be deemed to share voting and dispositive power with respect to the securities held by AH Bio Fund IV for itself and as nominee. F2: The Reporting Person serves as one of the members of AH EP Bio IV, but she disclaims the existence of a "group" (as that term is used in Section 13(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act")), and disclaims beneficial ownership of the securities directly held by AH Bio Fund IV, and this report shall not be deemed an admission that she is the beneficial owner of the securities reported herein for purposes of Section 16 of the Exchange Act, or for any other purpose, except to the extent of her pecuniary interest therein, if any. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported securities are held by AH Bio Fund IV, L.P. ("AH Bio Fund IV"), for itself and as nominee for AH Bio Fund IV-B, L.P., AH 2022 Annual Fund, L.P., AH 2022 Annual Fund-B, L.P., AH 2022 Annual Fund-QC, L.P. and CLF Partners III, LP. AH Equity Partners Bio IV, L.L.C. ("AH EP Bio IV") is the general partner of AH Bio Fund IV and has sole voting and dispositive power with regard to the securities held by AH Bio Fund IV for itself and as nominee. The managing members of AH EP Bio IV are Marc Andreessen and Ben Horowitz. Marc Andreessen and Ben Horowitz may be deemed to share voting and dispositive power with respect to the securities held by AH Bio Fund IV for itself and as nominee.
F2: The Reporting Person serves as one of the members of AH EP Bio IV, but she disclaims the existence of a "group" (as that term is used in Section 13(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act")), and disclaims beneficial ownership of the securities directly held by AH Bio Fund IV, and this report shall not be deemed an admission that she is the beneficial owner of the securities reported herein for purposes of Section 16 of the Exchange Act, or for any other purpose, except to the extent of her pecuniary interest therein, if any.
TENET HEALTHCARE CORP
Report date May 27, 2026 · Filed May 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| 2026 May Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2027-05-27 | Direct | 1,188 |
Reported balance
After 2026-05-27 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-27 · Grant · Acquired 1,188 · Balance 1,188 F1: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. These restricted stock units vest on the first anniversary of the date of grant. The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. These restricted stock units vest on the first anniversary of the date of grant. The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 27, 2026 Filed May 29, 2026 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Grant2026 May Restricted Stock Units · Derivative | 1,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-245814 · ownership.xml · derivative · entry 1 Agarwala Vineeta · CIK 0002003663 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,188 Underlying: Common Stock · 1,188 shares Expires 2027-05-27 F1 · derivative.exercise_price: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. These restricted stock units vest on the first anniversary of the date of grant. The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares. Read SEC document |
| May 22, 2026 Filed May 27, 2026 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2025 May Restricted Stock Units · Derivative | 1,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-239937 · ownership.xml · derivative · entry 2 Agarwala Vineeta · CIK 0002003663 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,333 shares Expires 2026-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. F1 · price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. Read SEC document |
| May 22, 2026 Filed May 27, 2026 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 1,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-239937 · ownership.xml · nonDerivative · entry 1 Agarwala Vineeta · CIK 0002003663 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,446 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. Read SEC document |
| May 23, 2025 Filed May 28, 2025 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionRestricted Stock Units · Derivative | 1,551 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-078015 · ownership.xml · derivative · entry 3 Agarwala Vineeta · CIK 0002003663 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,551 shares Expires 2025-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. F1 · price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. Read SEC document |
| May 23, 2025 Filed May 28, 2025 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 1,551 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-078015 · ownership.xml · nonDerivative · entry 1 Agarwala Vineeta · CIK 0002003663 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,113 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. Read SEC document |
| May 22, 2025 Filed May 28, 2025 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | GrantRestricted Stock Units · Derivative | 1,333 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-078015 · ownership.xml · derivative · entry 2 Agarwala Vineeta · CIK 0002003663 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,333 Underlying: Common Stock · 1,333 shares Expires 2026-05-22 F2 · derivative.exercise_price: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. These restricted stock units vest on the first anniversary of the date of grant. The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares. Read SEC document |
| May 23, 2024 Filed May 29, 2024 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | GrantRestricted Stock Units · Derivative | 1,551 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-065555 · ownership.xml · derivative · entry 1 Agarwala Vineeta · CIK 0002003663 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,551 Underlying: Common Stock · 1,551 shares Expires 2025-05-23 F1 · derivative.exercise_price: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. These restricted stock units vest on the first anniversary of the date of grant. The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares. Read SEC document |
| December 11, 2023 Filed Dec 13, 2023 22:07 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | GrantCommon Stock | 1,562 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-058525 · doc4.xml · nonDerivative · entry 1 Agarwala Vineeta · CIK 0002003663 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,562 F1 · security: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). F1 · shares: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.